Related Experiment Videos
Summary
Fixed drug eruption can occur with sulindac (Clinoril). This case highlights unusual hypopigmentation during lesion healing, emphasizing physician awareness of this adverse drug reaction.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Medicine
Background:
- Fixed drug eruption (FDE) is a specific type of adverse drug reaction.
- Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) with common clinical use.
Observation:
- A patient presented with a fixed drug eruption attributed to sulindac.
- The patient exhibited an unusual manifestation of hypopigmentation as the FDE lesion healed.
Findings:
- The case demonstrates sulindac as a potential cause of fixed drug eruption.
- Hypopigmentation was observed during the resolution phase of the sulindac-induced FDE.
Implications:
- Physicians should consider sulindac when diagnosing fixed drug eruption.
- Awareness of FDE and its potential sequelae, like hypopigmentation, is crucial for patient management.